Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 11/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17656047 | 1.00 | KDR (0.52) | KDRMAPTKMT2ANPSR1PTK2B | |
| SCHEMBL17655958 | 0.94 | KDR (0.55) | KDRMAPTKMT2ANPSR1PTK2B | |
| SCHEMBL17655940 | 0.89 | KDR (0.50) | KDRMAPTKMT2ANPSR1PTK2B | |
| SCHEMBL17655827 | 0.89 | KDR (0.50) | KDRMAPTKMT2ANPSR1PTK2B | |
| SCHEMBL17655920 | 0.89 | KDR (0.50) | KDRMAPTKMT2ANPSR1PTK2B | |
| SCHEMBL17655886 | 0.89 | KDR (0.50) | KDRMAPTKMT2ANPSR1PTK2B | |
| SCHEMBL17655803 | 0.89 | MAPT (0.62) | MAPTKMT2ANPSR1PTK2BFGFR1 | |
| SCHEMBL17655892 | 0.89 | MAPT (0.62) | MAPTKMT2ANPSR1PTK2BFGFR1 | |
| SCHEMBL23099348 | 0.85 | KDR (0.57) | KDRMAPTKMT2ANPSR1PTK2B | |
| SCHEMBL17754443 | 0.85 | KDR (0.57) | KDRMAPTKMT2ANPSR1PTK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3002282-B1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2019-01-02 | — | — | EP | disclosed |
| US-9882145-B2 | Hetero ring compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-9882145-B2 | Hetero ring compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-20160141514-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| US-20160141514-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| EP-3002282-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG Chem, Ltd. (KR) | 2016-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160141514-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | CRY1, CRY2, PER2 | KDR 2003/4885MAPT 329/4885KMT2A 530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.